Drug Utilization Review 2000 Index
Drug Utilization Review 2000 Index
Clinical pharmacy
After the party’s over: the effects of alcohol, MAR:19
Caring for an aging America: pharmacists have a critical role, JUNE:41
Choosing formulary antimicrobials? Your expertise should be the key, FEB:9
Drug aids care of diabetic peripheral neuropathy, FEB:15
Get to know your patients, St. John’s Wort(s) and all, JULY:49
Fending off antimicrobial resistance is a battle of constant attack, research, DEC: 89
Lupus — a real trial is held this time, DEC:92
Mission possible: making the Internet safe for private patient information, OCT:73
Pharmacists assess their roles in the world of bioterrorism, SEPT:65
Pharmacists play role in fighting breast cancer, JUNE:43
Pharmacists start clinics to help reduce lipid levels, SEPT:67
Rezulin comes under fire as LA Times alleges more adverse reactions, MAR:17
Technology takes a role in reducing medication errors, AUG:57
With Lotronex, a guide is part of the package, OCT:74
When asked about RU486, keep these notes handy, NOV:84
Medication use evaluations
A pox on chickenpox: a guide to treating children, MAR:1
A review of tranexamic acid (Cyklokapron), MAY:1
Alosetron (Lotronex) for irritable bowel syndrome, AUG:1
Aspirin/extended-release dipyridamole (Aggrenox) for secondary prevention of stroke, DEC:1
Daclizumab (Zenapax) for renal transplant patients, JULY:1
Doxercalciferol (Hectorol) for patients undergoing renal dialysis, OCT:4
Gatifloxacin (Tequin): observations on its use, JUNE:1
HMG-CoA reductase inhibitors in treating dyslipidemias, JAN:1
Infliximab (Remicade) for rheumatoid arthritis symptoms, NOV:1
Meloxicam (Mobic) for relief of osteoarthritis symptoms, OCT:1
Nitric oxide (INOmax) for newborns, JULY:5
Pharmacists and VAERS: unearthing the adverse, MAR:4
Pneumococcal 7-valent conjugate vaccine for infants and toddlers, AUG:4
Rivastigmine (Exelon) for treatment of Alzheimer’s, SEPT:1
Ofloxacin (Ocuflox) for conjunctivitis and corneal ulcers, DEC:5
The evidence grows regarding use of ACEIs and aspirin, APR:1
Understanding antimicrobial desensitization protocols, FEB:1
Pharmacy practice
Employee retention: everyone has a stake (Part I), JULY:52
Employee retention: everyone has a stake (Part II), AUG:59
In new era, pharmacists become more than just dispensers of drugs, MAY:33
Life on the job: pharmacists concerned about workplace quality, JAN:1
New twist on pharmacy e-commerce marketplace, APR:27
1999 DUR salary survey, JAN:SUP
Survey finds patients worry about errors, JAN:7
More opportunities to practice than there are pharmacists, APR:25
The future is here as genetically engineered drugs enter the hospital, NOV:81
2000 Salary survey results, NOV:SUP
Pocket brain
Absolute neutrophil count, JULY:56
Creatinine clearance formulas, APR:32
Conversion equivalents, AUG:64
Drugs that can cause SLE, DEC:93
Equivalence codes, OCT:80
Pregnancy definitions, NOV:88
Pregnancy risk factors, MAY:39
Temperature conversions, JUNE:48
Tyramine-containing foods; MAR:20
Regulation and accreditation
California labor law adds pharmacists, JAN:6
CDC stresses guidelines for S. aureus testing, MAR:23
Core measures identified by Joint Commission, JUNE:44
FDA issues call for wise prescribing of antivirals, MAR:22
HHS’ year 2000 report: no stockpiling of drugs, MAR:22
ISMP, AHA lead national program on drug safety, FEB:12
Propulsid warning emphasized, MAR:21
Searle sends a warning about Misoprostol use, OCT:79
Surgeon General reveals new health strategy, MAR:21
Resources
Clinical trials information Web site is launched, APR:30
Free continuing education credits from ISMP, SEPT:70
Merck offers vaccine site, APR:29
New FDA web site, MAR:21
New format available for MSDS database, MAY:39
New health book available, MAY:38
Need back issues? Call our order department at (800) 688-2421; inside Georgia (404) 262-7436.
Subscribe Now for Access
You have reached your article limit for the month. We hope you found our articles both enjoyable and insightful. For information on new subscriptions, product trials, alternative billing arrangements or group and site discounts please call 800-688-2421. We look forward to having you as a long-term member of the Relias Media community.